Irrimax Corporation

Irrimax Corporation is a U.S.-based medical device company that specializes in advanced wound irrigation solutions. Founded as a pioneer in this field, the company introduced its flagship product, Irrisept®, in 2010. This self-contained jet lavage system uses a low-pressure irrigation method with a solution of low-concentration chlorhexidine gluconate (CHG) and sterile water, providing broad-spectrum antimicrobial activity. Irrisept® is designed to cleanse wounds effectively, promoting better healing by removing debris and microorganisms. Irrimax aims to set the standard of care for wound irrigation, focusing on preventing surgical site infections and reducing the reliance on systemic antibiotics. The company serves a wide range of healthcare settings, including pre-hospital care, acute wound care, and surgical site irrigation. With over 4,500 hospitals in the U.S. using its products, Irrimax is recognized for its commitment to high product quality and excellent customer service. The company is a wholly owned subsidiary of Innovation Technologies, Inc., which holds the global patents for its innovative technology.

• Employees 88
• Founded 2003
• Annual Revenue $7000000